Planning for a National Non-Communicable Disease Center of Research Excellence

规划国家非传染性疾病卓越研究中心

基本信息

  • 批准号:
    9337384
  • 负责人:
  • 金额:
    $ 25.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Abstract This application is in response to RFA-CA15-007. It comprises a two-year planning period to develop a Malawi Center of Research Excellence for non-communicable diseases (NCDs), focused on cancer, injury, and cardiovascular disease (CVD). These three areas of concentration are of major public health importance with immense unmet need. They have been prioritized by our partner institutions in this application: the Malawi College of Medicine (COM) and Ministry of Health (MOH). Following the intent of the RFA the University of North Carolina (UNC) will serve as the high-income country partner institution for the application, based on its decades-long program in Malawi, long history of collaboration with COM and MOH, and deep involvement in cancer research activities specifically within Malawi. The planning grant will seek to engage US and International partners with significant NCD programs in Malawi, such as UCLA and Baylor College of Medicine, and others. This is a multiple principal investigators application with highly complementary expertise: Satish Gopal (UNC/COM; cancer; clinical investigation); Nyengo Mkandawire (COM; injury; clinical investigation); Mwapatsa Mipando (COM; cardiovascular disease; basic science); Dirk Dittmer (UNC; cancer; basic science). In addition, senior investigators and leadership from government and other supported research programs will participate as key personnel and consultants during the planning period, which leverages an impressive pool of faculty within and outside Malawi. The planning is to develop a center will include administrative, developmental, clinical, laboratory, biostatistics, and implementation cores and which may serve as a resource for the region, e.g. in pathology and surgery training. Partners will be invited during the planning period to contribute to a national plan for each of these, based on existing resources and activities across institutions, as well as new resources and activities that are collectively prioritized. Sustainability of the proposed center and its impact will be ensured by strong ownership from collaborating Malawian partners, including support by the highest levels of COM and MOH. We seek to establish active linkages of collaborating partners within Malawi to international institutions and research networks outside Malawi will allow the center to leverage these external relationships to achieve regional importance in sub-Saharan Africa. Finally, by catalyzing a broad national movement to address a rapidly growing NCD burden, the center will deliver measurable benefits to the people of Malawi.
项目摘要 本申请是对RFA-CA 15 -007的响应。它包括一个为期两年的规划期, 非传染性疾病(NCDs)卓越研究中心,专注于癌症,伤害和 心血管疾病(CVD)。这三个重点领域对公共卫生具有重大意义, 巨大的未满足的需求。我们的伙伴机构在这一申请中优先考虑这些项目: 医学院(COM)和卫生部(MOH)。根据RFA的意图, 北卡罗来纳州将作为申请的高收入国家伙伴机构,基于其 在马拉维长达数十年的计划,与COM和MOH的长期合作历史,以及深入参与 癌症研究活动,特别是在马拉维。规划赠款将寻求参与我们和 在马拉维开展重大非传染性疾病项目的国际合作伙伴,如加州大学洛杉矶分校和贝勒医学院, 等人这是一个多个主要研究者的应用程序,具有高度互补的专业知识:Satish Gopal(CIMB/COM;癌症;临床研究); Nyengo Mkandawire(COM;损伤;临床研究); Mwapatsa Mipando(COM;心血管疾病;基础科学); Dirk Dittmer(癌症;基础科学)。 此外,来自政府和其他支持研究项目的高级研究人员和领导将 在规划期间作为关键人员和顾问参与,利用了令人印象深刻的 马拉维国内外的教师。规划是开发一个中心将包括行政, 开发、临床、实验室、生物统计和实施核心,可作为资源 为该区域提供的培训,例如病理学和外科培训。在规划期间,将邀请合作伙伴 在现有资源和各机构活动的基础上,为每一项活动制定国家计划, 以及集体确定优先次序的新资源和活动。拟建中心的可持续性, 其影响将通过马拉维合作伙伴的强有力的自主权来确保,包括 最高级别的COM和MOH。我们寻求在马拉维境内建立合作伙伴的积极联系 马拉维以外的国际机构和研究网络将使该中心能够利用这些 对外关系,以实现在撒哈拉以南非洲地区的重要性。最后,通过催化广泛的 为了解决快速增长的非传染性疾病负担,该中心将为国家带来可衡量的好处, 马拉维人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dirk P Dittmer其他文献

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
  • DOI:
    10.1186/1750-9378-7-s1-o9
  • 发表时间:
    2012-04-19
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Dirk P Dittmer;Blossom Damania;Sang-Hoon Sin;Debasmita Roy
  • 通讯作者:
    Debasmita Roy
The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas
  • DOI:
    10.1186/1750-9378-5-s1-a81
  • 发表时间:
    2010-10-11
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Ulas Darda Bayraktar;Eileen Bernal;Lisa Cabral;William J Harrington;Dirk P Dittmer;Juan Carlos Ramos
  • 通讯作者:
    Juan Carlos Ramos

Dirk P Dittmer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dirk P Dittmer', 18)}}的其他基金

PQ6: Transgenic Mouse Model for Kaposi Sarcoma
PQ6:卡波西肉瘤转基因小鼠模型
  • 批准号:
    10334549
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
  • 批准号:
    10434864
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
  • 批准号:
    10652401
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
  • 批准号:
    10084558
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
PQ6: Transgenic Mouse Model for Kaposi Sarcoma
PQ6:卡波西肉瘤转基因小鼠模型
  • 批准号:
    10579826
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
PQ6: Transgenic Mouse Model for Kaposi Sarcoma
PQ6:卡波西肉瘤转基因小鼠模型
  • 批准号:
    10115683
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
项目 2:马拉维和南非当地标准护理治疗下 HIV 相关卡波西肉瘤进展的临床和分子决定因素
  • 批准号:
    10238161
  • 财政年份:
    2020
  • 资助金额:
    $ 25.18万
  • 项目类别:
Planning for a National Non-Communicable Disease Center of Research Excellence
规划国家非传染性疾病卓越研究中心
  • 批准号:
    9193832
  • 财政年份:
    2016
  • 资助金额:
    $ 25.18万
  • 项目类别:
Origin and Lineage of Differentiation of Kaposi's Sarcoma
卡波西肉瘤的起源和分化谱系
  • 批准号:
    8839925
  • 财政年份:
    2015
  • 资助金额:
    $ 25.18万
  • 项目类别:
HIV and substances of abuse influence exosomes and endothelial cell function
HIV 和滥用物质影响外泌体和内皮细胞功能
  • 批准号:
    9304176
  • 财政年份:
    2015
  • 资助金额:
    $ 25.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了